| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |